Patient-specific compartmental models for [177Lu]LuPSMA-617 therapy

被引:0
|
作者
Li, W. [1 ]
Kupitz, D. [2 ,3 ]
Spielmann, V. [1 ]
Kamp, A. [1 ]
Katzdobler, L. [1 ]
Giussani, A. [1 ]
Kreissl, M. [2 ,3 ,4 ]
Grosser, O. [2 ,3 ,4 ]
机构
[1] Bundesamt Strahlenschutz, Oberschleissheim, Germany
[2] Otto von Guericke Univ, Univ Hosp Magdeburg, Dept Radiol & Nucl Med, Magdeburg, Germany
[3] Otto von Guericke Univ, Fac Med, Magdeburg, Germany
[4] Otto von Guericke Univ, Res Campus STIMULATE, Magdeburg, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0920
引用
收藏
页码:S799 / S800
页数:2
相关论文
共 50 条
  • [11] Patient-specific dosimetric workflow with a reduced number of time-points for 177Lu treatments
    Vergnaud, L.
    Giraudet, A. L.
    Moreau, A.
    Baudier, T.
    Kryza, D.
    Badel, J. N.
    Sarrut, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S394 - S394
  • [12] [177Lu]Lu-PSMA-617 theranostic probe for hepatocellular carcinoma imaging and therapy
    Lu, Qiaomiao
    Long, Yu
    Gai, Yongkang
    Liu, Qingyao
    Jiang, Dawei
    Lan, Xiaoli
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (08) : 2342 - 2352
  • [13] Urinary excretion kinetics of [177Lu]Lu-PSMA-617
    Maarten de Bakker
    Noa Dominicus
    Antoi Meeuwis
    Marcel Janssen
    Mark W. Konijnenberg
    James Nagarajah
    Steffie M. B. Peters
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3572 - 3575
  • [14] Urinary excretion kinetics of [177Lu]Lu-PSMA-617
    de Bakker, Maarten
    Dominicus, Noa
    Meeuwis, Antoi
    Janssen, Marcel
    Konijnenberg, Mark W. W.
    Nagarajah, James
    Peters, Steffie M. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3572 - 3575
  • [15] [177Lu]Lu-PSMA-617 theranostic probe for hepatocellular carcinoma imaging and therapy
    Qiaomiao Lu
    Yu Long
    Yongkang Gai
    Qingyao Liu
    Dawei Jiang
    Xiaoli Lan
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2342 - 2352
  • [16] Investigation of in vitro models to unravel salivary gland toxicity mechanisms after [177Lu]Lu-PSMA-617 therapy
    Heynickx, N.
    Segers, C.
    Baatout, S.
    Vermeulen, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S426 - S426
  • [17] Intricacies in the Preparation of Patient Doses of [177Lu]Lu-Rituximab and [177Lu]Lu-Trastuzumab Using Low Specific Activity [177Lu]LuCl3: Methodological Aspects
    Chakraborty, Avik
    Mitra, Arpit
    Sahu, Sudeep
    Tawate, Megha
    Lad, Sangita
    Kamaldeep
    Rakshit, Sutapa
    Bannore, Trupti Upadhye
    Gaikwad, Sujay
    Dhotre, Geetanjali
    Ray, Mukti Kanta
    Damle, Archana
    Basu, Sandip
    Banerjee, Sharmila
    MOLECULAR IMAGING AND BIOLOGY, 2024, 26 (01) : 61 - 80
  • [18] Intricacies in the Preparation of Patient Doses of [177Lu]Lu-Rituximab and [177Lu]Lu-Trastuzumab Using Low Specific Activity [177Lu]LuCl3: Methodological Aspects
    Avik Chakraborty
    Arpit Mitra
    Sudeep Sahu
    Megha Tawate
    Sangita Lad
    Sutapa Kamaldeep
    Trupti Rakshit
    Sujay Upadhye Bannore
    Geetanjali Gaikwad
    Mukti Kanta Dhotre
    Archana Ray
    Sandip Damle
    Sharmila Basu
    Molecular Imaging and Biology, 2024, 26 : 61 - 80
  • [19] Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using 177Lu-DKFZ-PSMA-617
    Mahmoudi, Elahe
    Pirayesh, Elahe
    Deevband, Mohammad Reza
    Amoui, Mahasti
    Rad, Mehrdad Ghorbani
    Ghorbani, Mahdi
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 55 (05) : 237 - 244
  • [20] Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using 177Lu-DKFZ-PSMA-617
    Elahe Mahmoudi
    Elahe Pirayesh
    Mohammad Reza Deevband
    Mahasti Amoui
    Mehrdad Ghorbani Rad
    Mahdi Ghorbani
    Nuclear Medicine and Molecular Imaging, 2021, 55 : 237 - 244